Long‐term risks and benefits of oral anticoagulation in atrial fibrillation patients with cancer: A report from the <scp>GLORIA</scp>‐<scp>AF</scp> registry
Cancer is a common comorbidity in patients with AF and is associated with increased risk of composite of all-cause mortality and thromboembolism. Compared with VKA, NOACs was associated with a lower risk of composite events and showed an advantage in lower risk of thromboembolism, as well as a reduced risk of major bleeding when CAD was also present.
Authors
- Tze‐Fan Chao (ORCID: https://orcid.org/0000-0002-6587-3094)
- Brian Olshansky (ORCID: https://orcid.org/0000-0002-6044-045X)
- Gregory Y.H. Lip (ORCID: https://orcid.org/0000-0002-7566-1626)
- Steven Ho Man Lam (ORCID: https://orcid.org/0000-0003-2147-0995)
- Hironori Ishiguchi (ORCID: https://orcid.org/0000-0003-4597-7862)
- Yang Liu (ORCID: https://orcid.org/0000-0003-4430-3452)
- Meng Li (ORCID: https://orcid.org/0000-0001-9695-6493)
- Menno V. Huisman
- Bi Huang
Institutions
- Nanchang University (CN)
- University of Liverpool (GB)
- National Yang Ming Chiao Tung University (TW)
- Yamaguchi University (JP)
- Leiden University Medical Center (NL)
- University of Iowa Hospitals and Clinics (US)
- Taipei Veterans General Hospital (TW)
- Liverpool Heart and Chest Hospital (GB)
- Second Affiliated Hospital of Nanchang University (CN)
- Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine (CN)
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- Liverpool John Moores University (GB)
- Chongqing Medical University (CN)
- Aalborg University (DK)
Publication Details
- Journal
- European Journal of Clinical Investigation
- Published
- 2024-11-13
- DOI
- https://doi.org/10.1111/eci.14347
- Citations
- 5
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 2.01